Fungal Mycelium Films Engineered as Renewable Fibrous Materials for Drug Delivery
Source abstract
Abstract
Sustainable materials are increasingly relevant in drug delivery technologies. Food-grade fungal mycelium, already widely consumed as part of the human diet, offers a renewable source of fibrous substrates. Here, we report mycelium films from Rhizopus oligosporus as a naturally derived biomaterial for use in oral drug delivery. R. oligosporus mycelium films were produced using solid-state cultivation, yielding porous, mechanically compliant structures that could be shaped into defined 3D geometries through micro-cutting and template-guided growth. These films accommodated small-molecule drug cargo and particulate formulations, acting either as passive carrier matrices or as structured interfaces that enabled modulation of drug release behavior in model systems. Biological interactions were evaluated using in vitro cell models and short-term in vivo gastrointestinal transit studies in rats, where no cytotoxic effects or abnormal passage were observed under the tested conditions. Together, these findings demonstrate the potential of mycelium films as sustainable, shape-malleable fibrous materials with tunable functional properties for future applications in oral drug delivery.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Plant and Biological Electrophysiology Studies · Slime Mold and Myxomycetes Research · Light effects on plants
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
The Danish National Research Foundation and Villum Foundation’s Center for Intelligent Drug Delivery and Sensing Using Microcontainers and Nanomechanics (IDUN), Department of Health Technology, Technical University of Denmark, Ørsteds Plads 345C, 2800 Kongens Lyngby, Denmark
The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Søltofts Plads 220, 2800 Kongens Lyngby, Denmark
Funding
European Research Council · Good Food Institute
References (60)
Show source-provided references
1. 10.1016/j.jclepro.2020.12120410.1016/j.jclepro.2020.121204 ↗
2. 10.1016/j.cogsc.2021.10056210.1016/j.cogsc.2021.100562 ↗
3. 10.1016/S2542-5196(25)00028-210.1016/S2542-5196(25)00028-2 ↗
4. 10.1186/s40694-019-0080-y10.1186/s40694-019-0080-y ↗
5. 10.1007/s11274-019-2723-910.1007/s11274-019-2723-9 ↗
6. 10.1021/acssuschemeng.3c0083110.1021/acssuschemeng.3c00831 ↗
7. 10.1126/sciadv.add711810.1126/sciadv.add7118 ↗
8. 10.1016/j.matdes.2019.10839710.1016/j.matdes.2019.108397 ↗
9. 10.1016/j.matpr.2017.09.21110.1016/j.matpr.2017.09.211 ↗
10. 10.1038/nrmicro251910.1038/nrmicro2519 ↗
11. 10.1111/1541-4337.1252010.1111/1541-4337.12520 ↗
12. 10.1016/0963-9969(94)90097-310.1016/0963-9969(94)90097-3 ↗
13. 10.1021/acs.jafc.5b0291410.1021/acs.jafc.5b02914 ↗
14. 10.1016/j.phytochem.2006.07.00410.1016/j.phytochem.2006.07.004 ↗
15. 10.1007/s11912-023-01408-210.1007/s11912-023-01408-2 ↗
16. 10.1016/j.cell.2022.12.00210.1016/j.cell.2022.12.002 ↗
17. 10.1111/1541-4337.1271010.1111/1541-4337.12710 ↗
18. 10.1016/j.addr.2020.05.00410.1016/j.addr.2020.05.004 ↗
19. 10.1111/j.1365-2958.2007.05872.x10.1111/j.1365-2958.2007.05872.x ↗
20. 10.1146/annurev.anchem.1.031207.11275410.1146/annurev.anchem.1.031207.112754 ↗
21. 10.1021/jp035693v10.1021/jp035693v ↗
22. 10.1016/j.jconrel.2023.10.04110.1016/j.jconrel.2023.10.041 ↗
23. 10.1002/jbm.a.3778510.1002/jbm.a.37785 ↗
24. Farag R. · 2009 · 5110.1533/9781845696801.1.51 ↗
25. 10.3390/pharmaceutics1204035510.3390/pharmaceutics12040355 ↗
26. 10.1016/S0168-3659(02)00074-310.1016/S0168-3659(02)00074-3 ↗
27. 10.1021/acsbiomaterials.9b0176010.1021/acsbiomaterials.9b01760 ↗
28. Thamdrup, L. H. E.; Boisen, A.; Ajalloueian, F. Monodisperse Nanofibrous Microparticles for Delivery of One or More Active Substances. WO 2024/184189 A1, 2024.
29. 10.3390/polym1301008310.3390/polym13010083 ↗
30. 10.1016/j.heliyon.2024.e3084410.1016/j.heliyon.2024.e30844 ↗
31. 10.1038/srep4129210.1038/srep41292 ↗
32. 10.1016/j.matdes.2018.11.02710.1016/j.matdes.2018.11.027 ↗
33. 10.1371/journal.pone.025782310.1371/journal.pone.0257823 ↗
34. 10.1038/s41396-020-00886-710.1038/s41396-020-00886-7 ↗
35. 10.1109/TBME.2020.298224210.1109/TBME.2020.2982242 ↗
36. 10.1016/j.clnu.2020.11.02910.1016/j.clnu.2020.11.029 ↗
37. 10.1155/2014/80584110.1155/2014/805841 ↗
38. 10.1002/med.2134810.1002/med.21348 ↗
39. 10.1016/j.copbio.2016.11.01010.1016/j.copbio.2016.11.010 ↗
40. 10.1038/s41598-022-14512-310.1038/s41598-022-14512-3 ↗
41. 10.1016/j.ejpb.2019.07.00710.1016/j.ejpb.2019.07.007 ↗
42. 10.1016/j.ijpharm.2016.03.05010.1016/j.ijpharm.2016.03.050 ↗
43. 10.1002/adtp.20220010610.1002/adtp.202200106 ↗
44. 10.1016/j.jconrel.2014.06.03610.1016/j.jconrel.2014.06.036 ↗
45. 10.1016/j.carbpol.2010.12.02310.1016/j.carbpol.2010.12.023 ↗
46. 10.3389/fnut.2022.97286010.3389/fnut.2022.972860 ↗
47. 10.1021/acsomega.4c0437810.1021/acsomega.4c04378 ↗
48. 10.3390/pharmaceutics1411253610.3390/pharmaceutics14112536 ↗
49. 10.1007/s00253-013-4736-x10.1007/s00253-013-4736-x ↗
50. 10.1023/A:100897462169810.1023/A:1008974621698 ↗
51. 10.1111/j.1365-2672.2004.02471.x10.1111/j.1365-2672.2004.02471.x ↗
52. 10.1093/cid/cir86410.1093/cid/cir864 ↗
53. 10.1111/j.1469-0691.2009.02972.x10.1111/j.1469-0691.2009.02972.x ↗
54. 10.1016/j.jconrel.2023.07.04110.1016/j.jconrel.2023.07.041 ↗
55. 10.1016/j.jconrel.2020.10.02410.1016/j.jconrel.2020.10.024 ↗
56. 10.1002/adhm.20220189710.1002/adhm.202201897 ↗
57. 10.1016/j.crfs.2024.10086610.1016/j.crfs.2024.100866 ↗
58. 10.1016/j.foodhyd.2023.10890710.1016/j.foodhyd.2023.108907 ↗
59. 10.1021/jp805424f10.1021/jp805424f ↗
60. 10.1021/jp305709y10.1021/jp305709y ↗